Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02816684 · ClinicalTrials.gov registry record · Phase 2
Pegasys VR: Integrating Virtual Humans in the Treatment of Child Social Anxiety
A Phase 2 study, sponsored by University of Central Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
NCT02816684 is a Phase 2 study that has completed, run by University of Central Florida. The registered enrollment target is 43 participants.
The verdict
NCT02816684, a Phase 2 study, has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
Study Summary
Among children, social anxiety is a common, severe and chronic disorder. Social Effectiveness Therapy for Children (SET-C) is an empirically supported treatment with significant potential to impact the lives of children with this severe and chronic disorder. The proposed Pegasys-VR™ system will distinctly enhance its utility, as it will allow dissemination to a broad variety of clinical settings including schools as well as traditional outpatient clinics. Its use for the treatment of social skills deficits will offer a superior solution for mental health personnel, solving many of the resource and logistic barriers that they currently face. The final product will address cost and practical issues by disseminating an empirically-supported treatment that was rigorously built and tested. Using VE will make the traditional social skills therapy programs program cost-effective and patient-centric, allowing even clinicians with little background/training in behavior therapy to have tools not typically available to them.
Interventions
- BEHAVIORAL Pegasys-VR
- BEHAVIORAL Social Effectiveness Therapy for Children
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02816684
The ClinicalTrials.gov registry entry for NCT02816684 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pegasys-VR is the first listed.
NCT02816684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02816684 about?
NCT02816684 is a clinical study titled "Pegasys VR: Integrating Virtual Humans in the Treatment of Child Social Anxiety". Among children, social anxiety is a common, severe and chronic disorder. Social Effectiveness Therapy for Children (SET-C) is an empirically supported treatment with significant potential to impact the lives of children with this severe and chronic disorder. The proposed Pegasys-VR™ system will dist...
What is the current status of trial NCT02816684?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2016-06. Estimated completion is 2018-08.
What interventions are being tested in trial NCT02816684?
The interventions under investigation include: Pegasys-VR (BEHAVIORAL), Social Effectiveness Therapy for Children (BEHAVIORAL).
Who is sponsoring clinical trial NCT02816684?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.